Literature DB >> 11259830

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

C A Lipinski1, F Lombardo, B W Dominy, P J Feeney.   

Abstract

Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP > 4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259830     DOI: 10.1016/s0169-409x(00)00129-0

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  2000 in total

1.  pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods.

Authors:  A Avdeef; C M Berger; C Brownell
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

2.  Synthesis and diversity analysis of lead discovery piperazine-2-carboxamide libraries.

Authors:  T F Herpin; G C Morton; A K Dunn; C Fillon; P R Menard; S Y Tang; J M Salvino; R F Labaudinière
Journal:  Mol Divers       Date:  1998       Impact factor: 2.943

3.  Experimental and computational screening models for prediction of aqueous drug solubility.

Authors:  Christel A S Bergström; Ulf Norinder; Kristina Luthman; Per Artursson
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

4.  Comments on the design of chemical libraries for screening.

Authors:  H O Villar; R T Koehler
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

5.  Estimation of aqueous solubility of organic compounds with QSPR approach.

Authors:  Hua Gao; Veerabahu Shanmugasundaram; Pil Lee
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

6.  Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties.

Authors:  P Stenberg; K Luthman; P Artursson
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

7.  The composite solubility versus pH profile and its role in intestinal absorption prediction.

Authors:  Barry A Hendriksen; Manuel V Sanchez Felix; Michael B Bolger
Journal:  AAPS PharmSci       Date:  2003

8.  Rate-limited steps of human oral absorption and QSAR studies.

Authors:  Yuan H Zhao; Michael H Abraham; Joelle Le; Anne Hersey; Chris N Luscombe; Gordon Beck; Brad Sherborne; Ian Cooper
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

Review 9.  Do drug metabolism and pharmacokinetic departments make any contribution to drug discovery?

Authors:  Dennis Smith; Esther Schmid; Barry Jones
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.

Authors:  Neeraj Kumar; Gulshan Bansal; Sandeep Kumar; Asim Kumar Jana
Journal:  AAPS PharmSciTech       Date:  2012-06-06       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.